{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:56:49Z","timestamp":1777388209245,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jneuroim.2025.578758","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:57:33Z","timestamp":1758574653000},"page":"578758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Epstein-Barr virus reactivation is associated with altered immune cell profiles in peripheral blood and cerebrospinal fluid of treatment-naive multiple sclerosis patients"],"prefix":"10.1016","volume":"409","author":[{"given":"Vasileios","family":"Gouzouasis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaritis","family":"Tsifintaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Tastsoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Markoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Karathanasis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lila","family":"Dimitrakopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Dagkonaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Korakidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Mpekoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niki","family":"Vassilaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artemis G.","family":"Hatzigeorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Anagnostouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eleftheria","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonis","family":"Giannakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Probert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jneuroim.2025.578758_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/WCO.0000000000000818","article-title":"Mechanisms underlying progression in multiple sclerosis","volume":"33","author":"Absinta","year":"2020","journal-title":"Curr. Opin. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578758_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009868","article-title":"NK cells eliminate Epstein-Barr virus bound to B cells through a specific antibody-mediated uptake","volume":"17","author":"Alari-Pahissa","year":"2021","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578758_bb0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578758_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0036-1579693","article-title":"Epidemiology of multiple sclerosis: from risk factors to prevention-an update","volume":"36","author":"Ascherio","year":"2016","journal-title":"Semin. Neurol."},{"issue":"16","key":"10.1016\/j.jneuroim.2025.578758_bb0025","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","article-title":"Role for early-differentiated natural killer cells in infectious mononucleosis","volume":"124","author":"Azzi","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jneuroim.2025.578758_bb0030","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tig.2017.09.004","article-title":"The genetics of multiple sclerosis: from 0 to 200 in 50 years","volume":"33","author":"Baranzini","year":"2017","journal-title":"Trends Genet."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578758_bb0035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances","volume":"20","author":"Bar-Or","year":"2021","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578758_bb0040","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","article-title":"Epstein-Barr Virus in multiple sclerosis: theory and emerging immunotherapies","volume":"26","author":"Bar-Or","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneuroim.2025.578758_bb0045","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.molmed.2021.01.004","article-title":"Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020). Vol. 27","author":"Bar-Or","year":"2021","journal-title":"Trends in Mol. Med."},{"issue":"23","key":"10.1016\/j.jneuroim.2025.578758_bb0050","doi-asserted-by":"crossref","first-page":"8705","DOI":"10.1073\/pnas.0402653101","article-title":"Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta","volume":"101","author":"Bielekova","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6578","key":"10.1016\/j.jneuroim.2025.578758_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"Pt 9","key":"10.1016\/j.jneuroim.2025.578758_bb0060","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1093\/brain\/awr199","article-title":"Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination","volume":"134","author":"Brambilla","year":"2011","journal-title":"Brain [Internet]."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578758_bb0065","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/imm.12808","article-title":"Programmed death 1 is highly expressed on CD8(+) CD57(+) T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus","volume":"152","author":"Cencioni","year":"2017","journal-title":"Immunology"},{"issue":"Pt 11","key":"10.1016\/j.jneuroim.2025.578758_bb0070","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/brain\/124.11.2169","article-title":"Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis","volume":"124","author":"Cepok","year":"2001","journal-title":"Brain"},{"issue":"Pt 7","key":"10.1016\/j.jneuroim.2025.578758_bb0075","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awh486","article-title":"Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis","volume":"128","author":"Cepok","year":"2005","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578758_bb0080","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","article-title":"Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection","volume":"5","author":"Chijioke","year":"2013","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578758_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cyto.b.20542","article-title":"Central memory CD4+ T cells dominate the normal cerebrospinal fluid","volume":"80","author":"de Graaf","year":"2011","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.jneuroim.2025.578758_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102921","article-title":"Neutrophil-lymphocyte ratio as a marker for disability and activity in multiple sclerosis","volume":"51","author":"Fahmi","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578758_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175279","article-title":"Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis","volume":"12","author":"Gie\u00df","year":"2017","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.jneuroim.2025.578758_bb0105","doi-asserted-by":"crossref","first-page":"E2973","DOI":"10.1073\/pnas.1524924113","article-title":"Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation","volume":"113","author":"Gross","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578758_bb0110","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/brain\/awab147","article-title":"Classification of neurological diseases using multi-dimensional CSF analysis","volume":"144","author":"Gross","year":"2021","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578758_bb0115","article-title":"The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis","volume":"4","author":"Hasselbalch","year":"2018","journal-title":"Mult Scler J - Exp Transl Clin."},{"key":"10.1016\/j.jneuroim.2025.578758_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftae002","article-title":"Awakening the sleeping giant: Epstein-Barr virus reactivation by biological agents","volume":"82","author":"Indari","year":"2024","journal-title":"Pathog Dis."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578758_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jneuroim.2003.10.001","article-title":"Clinical relapses of multiple sclerosis are associated with \u201cnovel\u201d valleys in natural killer cell functional activity","volume":"145","author":"Kastrukoff","year":"2003","journal-title":"J. Neuroimmunol."},{"issue":"2\u20133","key":"10.1016\/j.jneuroim.2025.578758_bb0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-5728(88)90164-6","article-title":"T-cell subsets in the cerebrospinal fluid and blood of patients with multiple sclerosis","volume":"20","author":"K\u00f6lmel","year":"1988","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00415-013-7145-2","article-title":"Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases","volume":"261","author":"Kowarik","year":"2014","journal-title":"J. Neurol."},{"issue":"14","key":"10.1016\/j.jneuroim.2025.578758_bb0140","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1177\/1352458514533843","article-title":"Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis","volume":"20","author":"Kvistad","year":"2014","journal-title":"Mult. Scler."},{"issue":"7900","key":"10.1016\/j.jneuroim.2025.578758_bb0145","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578758_bb0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1212\/WNL.35.3.435","article-title":"Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis","volume":"35","author":"Larsen","year":"1985","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578758_bb0155","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1468-1331.2010.03005.x","article-title":"Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis","volume":"17","author":"Lindsey","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/NEN.0b013e31827bfc62","article-title":"B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis","volume":"72","author":"Magliozzi","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578758_bb0165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clim.2011.09.006","article-title":"Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis","volume":"141","author":"Mart\u00ednez-Rodr\u00edguez","year":"2011","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578758_bb0170","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.jneuroim.2025.578758_bb0175","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/WNL.0000000000002099","article-title":"No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT","volume":"85","author":"Munger","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578758_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0165-5728(95)00115-9","article-title":"Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls","volume":"62","author":"Munschauer","year":"1995","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578758_bb0185","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/vim.2016.0179","article-title":"Epstein-Barr Virus lytic reactivation activates B cells polyclonally and induces activation-induced cytidine deaminase expression: a mechanism underlying autoimmunity and its contribution to graves\u2019 disease","volume":"30","author":"Nagata","year":"2017","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0190","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12964-023-01324-9","article-title":"Natural killer cells in the central nervous system","volume":"21","author":"Ning","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0195","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-021-00423-w","article-title":"Methods to investigate intrathecal adaptive immunity in neurodegeneration","volume":"16","author":"Oh","year":"2021","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578758_bb0200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0404.1998.tb01739.x","article-title":"Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system","volume":"98","author":"Oreja-Guevara","year":"1998","journal-title":"Acta Neurol. Scand."},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578758_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.25","article-title":"Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy","volume":"3","author":"Pender","year":"2014","journal-title":"Clin Transl Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.87","article-title":"Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin Transl Immunol."},{"key":"10.1016\/j.jneuroim.2025.578758_bb0215","first-page":"355","article-title":"Immune evasion by Epstein-Barr Virus","volume":"391","author":"Ressing","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578758_bb0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cei.12580","article-title":"Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis","volume":"180","author":"Rodr\u00edguez-Mart\u00edn","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0022-510X(92)90193-O","article-title":"T-cell phenotypic profiles in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients","volume":"108","author":"Scolozzi","year":"1992","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jneuroim.2025.578758_bb0230","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578758_bb0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0165-5728(95)00126-3","article-title":"Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid","volume":"63","author":"Svenningsson","year":"1995","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578758_bb0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"26","key":"10.1016\/j.jneuroim.2025.578758_bb0245","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2025.578758_bb0250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0022-510X(89)90222-0","article-title":"Natural killer cell number and activity in multiple sclerosis","volume":"94","author":"Vranes","year":"1989","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578758_bb0255","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.55.2.178","article-title":"Association between clinical disease activity and Epstein-Barr virus reactivation in MS","volume":"55","author":"Wandinger","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578758_bb0260","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11481-020-09948-1","article-title":"Antibodies from multiple sclerosis brain identified Epstein-Barr Virus nuclear antigen 1 & 2 epitopes which are recognized by oligoclonal bands","volume":"16","author":"Wang","year":"2021","journal-title":"J neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578758_bb0265","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","article-title":"The immune response to primary EBV infection: a role for natural killer cells","volume":"129","author":"Williams","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jneuroim.2025.578758_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907994","article-title":"Alterations of NK cell phenotype during pregnancy in multiple sclerosis","volume":"13","author":"Wisgalla","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:45:17Z","timestamp":1768387517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825002395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":54,"alternative-id":["S0165572825002395"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578758","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus reactivation is associated with altered immune cell profiles in peripheral blood and cerebrospinal fluid of treatment-naive multiple sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578758"}}